SUCCESSFUL TREATMENT WITH ADALIMUMAB IN INFLIXIMAB‐RESISTANT CROHN's DISEASE
- 10 August 2005
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 20 (9), 1464-1465
- https://doi.org/10.1111/j.1440-1746.2005.03848.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Safety and Efficacy of Adalimumab (D2E7) in Crohn's Disease Patients with an Attenuated Response to InfliximabThe American Journal of Gastroenterology, 2005
- An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's DiseaseThe American Journal of Gastroenterology, 2004
- A Pilot Study of Adalimumab in Infliximab-Allergic PatientsInflammatory Bowel Diseases, 2004
- Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor AntagonistAnnals of Internal Medicine, 2003
- Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitisAnnals Of The Rheumatic Diseases, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002